Skip to main content

Direct Filing Into The MDL Granted For Atrium C-Qur Cases

Direct Filing Into The MDL Granted For Atrium C-Qur Cases

Direct Filing Into The MDL Granted For Atrium C-Qur Cases

Introduction

U.S. District Judge Landya McCafferty presiding over all Atrium hernia mesh lawsuits approved new procedures in a case management order issued on February 19, for the direct filing of cases into the multidistrict litigation (MDL) in New Hampshire.  

The order was issued to avoid the delay in transferring cases from different district courts. In addition, an order was issued on February 15, which sanctioned an extension request filed by parties to give them time until April 1, 2019, to select the group of cases to be included in the first bellwether trials. The bellwether will be useful in measuring how juries might respond to certain evidence and testimony throughout the litigation. Though the results of these bellwether trials will not bind on other claims, the process was designed to clear the path for potential hernia mesh settlements to avoid the possibilities of hundreds of individual trials in various U.S. District Courts.

More than 1,000 hernia mesh lawsuits are pending against Atrium in the federal court system, each raising similar allegations that the C-Qur mesh has design defects and was unreasonably dangerous, and increased the need of additional corrective surgeries to remove or replace the patch.  

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!